Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.49 |
| ▸ | CNR1 | P21554 | 9/20 | 0.47 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | KMO | O15229 | 1/20 | 0.39 |
| ▸ | QDPR | P09417 | 2/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5358900 | 0.80 | CNR2 (0.50) | CNR2CNR1 | |
| SCHEMBL778084 | 0.80 | CYP11B2 (0.46) | ACMSDHDAC4HDAC2HDAC8KMO | |
| SCHEMBL263798 | 0.78 | ACMSD (0.46) | CNR2ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL778085 | 0.77 | HDAC8 (0.43) | ACMSDHDAC4HDAC2HDAC8KMO | |
| SCHEMBL2031629 | 0.76 | ACMSD (0.44) | CNR2ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL11555634 | 0.76 | ACMSD (0.44) | CNR2ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL2029212 | 0.76 | ACMSD (0.44) | CNR2ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL68815 | 0.76 | QDPR (0.66) | ACMSDHDAC4HDAC2HDAC8KMO | |
| SCHEMBL11166103 | 0.75 | HDAC4 (0.45) | ACMSDHDAC4HDAC2HDAC8KMO | |
| SCHEMBL7531576 | 0.74 | HDAC4 (0.50) | CNR2CNR1ACMSDHDAC4HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |